Background: Neutrophil extracellular traps (NETs) are immunogenic, extracellular DNA structures that harness important autoantigens to be recognized by the adaptive immune system. NETs are thought to play a pivotal role in the pathogenesis of many systemic autoimmune diseases including ANCA-associated vasculitis (AAV) and systemic lupus erytematosus (SLE). However it is still unclear how and if NETs can act as a common pathway in the pathophysiology of these clinically divergent autoimmune diseases. Objectives: To investigate the characteristics of NETs induced by sera of AAV and SLE patients. Methods: The present study involved 101 AAV patients, 59 SLE patients and 10 healthy controls. Healthy neutrophils were stimulated with 10% serum of these patients to induce NETs. Quantity of NET induction was measured by a novel, highly-sensitive NET quantification assay using 3D-confocal laser scanning microscopy 1 . Qualitative characteristics of NETs were investigated by immunofluorescence microscopy that detected co-localisation of several established autoantigens and NET-markers on AAV-and SLE-induced NETs, including citrullinated histon-3 (CitH3), neutrophil elastase (NE), high mobility group box-1 (HMGB1), myeloperoxidase (MPO) and proteinase-3 (PR3). Additionally, the morphology and kinetics of AAV-and SLE-induced NETosis were visualized by live imaging and electron microscopy. Results: Quantifying ex vivo NET induction demonstrated that AAV sera induced significant more NETs (median [Q1 -Q3]: 20.74 [9.56 -74.14]), compared to SLE sera (5.02 [1.88 -14.33]). Also qualitatively, NETs induced by AAV or SLE sera were distinct. In both cases, NETs showed co-localisation of MPO and PR3 with extracellular DNA. However, AAV-induced NETs had significantly higher Cith3 expression than SLE-induced NETs. Interestingly, the opposite was observed for other markers as HMGB1 was exclusively expressed on SLE-induced NETs and NE was also higher expressed on SLE-induced NETs compared to AAV-induced NETs. Intriguingly, the distinction between AAV and SLE NETs was further corroborated by live imaging demonstrating differences in morphology and chronology of NET induction: in SLE NET-clusters were induced within the 1st hour while in AAV non-clustered NETs composed of long, thin DNA-fibres were induced in 2-4 hours through lytic expulsion.
SAT0016 A NEW SUBSET OF NK CELLS, WITH ENHANCED CYTOTOXIC FUNCTION, IS INCREASED IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Adaptive immunity (T cells and B cells) in rheumatic diseases
Background: Granulomatosis with polyangiitis (GPA) is a disease characterized by inflammation in small blood vessels, leading to significant organ damage and ultimately great morbidity and mortality. The presence of anti-neutrophil cytoplasmic antibodies (ANCAs) is a hallmark of the disease, and thought to directly play a role in pathogenesis by activating primed neutrophils. The two major antigens that ANCAs are believed to recognize are myeloperoxidase (MPO) and proteinase 3 (PR3). Although anti-MPO antibodies are directly pathogenic when transferred or induced in animal models, the evidence is less clear for PR3. Clinically, it is debated whether levels of anti-PR3 correlate with disease activity. Therefore, we believe that anti-PR3 antibodies are not the primary drivers of disease in patients with PR3+ ANCA-vasculitis (i.e. GPA), and that novel autoantibodies may play a role in disease pathogenesis. Objectives: The objective of this work is to identify the human autoantigen targets of novel autoantibodies identified in GPA, and to test their association with disease. The goal is to discover novel autoantigens that will ultimately lead to new diagnostics and therapeutics. Methods: Cell-barcode-enabled antibody repertoire sequencing was performed on blood plasmablasts (antibody-producing cells formed during an immune response) from five PR3+ ANCA-vasculitis patients with GPA treated with rituximab in the RAVE trial. Phylogenetic trees were bioinformatically created in order to identify clonal families of plasmablasts. Antibodies representing clonal families of plasmablasts were recombinantly expressed and are being tested using human protein arrays and ELISAs to determine their antigen specificity. Results: All five PR3+ ANCA-vasculitis patients sequenced from the RAVE trial achieved complete remission but subsequently flared. Plasmablasts were isolated at the baseline flare, at remission and at the post-rituximab flare. Phylograms of the antibody repertoires revealed clonal families of affinity-matured antibodies that share heavy and light chain VJ usage. A total of 24 representative antibodies were selected for recombinant expression, including representative antibodies derived from clonal families: (1) shared across patients at baseline flare and/or post-rituximab flare (n=5), (2) 
